Skip to main content

Table 4 Logistic regression of poor functional outcomes according to FBG/HbA1c quartiles

From: Fasting blood glucose-to-glycated hemoglobin ratio and all-cause mortality among Chinese in-hospital patients with acute stroke: a 12-month follow-up study

Outcomes

FBG/HbA1c

n

Events, n (%)

Crude OR (95% CI)

p Value

Adjusted OR (95% CI)a

p Value

Secondary Outcomes: after discharge

 Poor functional outcomes (mRS of 3–6) at 3 months

Q1 (≤ 0.81)

214

32 (16.4)

Ref

 

Ref

 

Q2 (0.82–0.91)

212

46 (21.7)

1.42 (0.87–2.31)

0.161

1.50 (0.85–2.65)

0.159

Q3 (0.92–1.06)

210

50 (23.8)

1.64 (1.02–2.65)

0.043

1.16 (0.66–2.05)

0.601

Q4 (≥ 1.07)

210

72 (34.3)

2.67 (1.68–4.23)

 < 0.001

1.33 (0.75–2.36)

0.341

 Poor functional outcomes (mRS of 3–6) at 12 months

Q1 (≤ 0.81)

183

52 (28.4)

Ref

 

Ref

 

Q2 (0.82–0.91)

189

49 (25.9)

0.88 (0.56–1.39)

0.589

1.16 (0.68–1.99)

0.582

Q3 (0.92–1.06)

190

57 (30.0)

1.08 (0.69–1.69)

0.737

0.94 (0.55–1.59)

0.803

Q4 (≥ 1.07)

181

83 (45.9)

2.13 (1.38–3.29)

0.001

1.68 (0.97–2.90)

0.062

  1. Quartiles of FBG/HbA1c ratio, Q1 ≤ 0.81, 0.82 ≤ Q2 < 0.91, 0.92 ≤ Q3 < 1.06, Q4 ≥ 1.07
  2. FBG Fasting blood glucose, HbA1c Glycated hemoglobin
  3. aLogistic regression is adjusted for sex, age, NIHSS, type of stroke, atrial fibrillation, hypertension, diabetes, coronary heart disease, hyperlipemia, previous stroke, history of smoking, history of drinking, and infectious complications